Literature DB >> 18804499

Delivery of siRNA into the cytoplasm by liposomal bubbles and ultrasound.

Yoichi Negishi1, Yoko Endo, Tetsuya Fukuyama, Ryo Suzuki, Tomoko Takizawa, Daiki Omata, Kazuo Maruyama, Yukihiko Aramaki.   

Abstract

Small interfering RNA (siRNA) is expected to be a novel therapeutic tool, however, its utilization has been limited by inefficient delivery systems. Recently, we have developed novel polyethyleneglycol modified liposomes (Bubble liposomes; BL) entrapping an ultrasound (US) imaging gas, which can work as a gene delivery tool with US exposure. In this study, we investigated whether the BL were suitable for the delivery of siRNA. BL efficiently delivered siRNA with only 10 s of exposure to US in vitro. Specific gene silencing effects could be achieved well even in the presence of serum or with the disruption of endocytosis. We suggest that siRNA is directly introduced into the cytoplasm by the BL and US and the mechanism enables effective transfection within a short time and in the presence of high serum. Transfection of siRNA into the tibialis muscles with BL and US was also performed. The gene-silencing effect could be sustained for more than 3 weeks. Thus, BL could be a useful siRNA delivery tool in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804499     DOI: 10.1016/j.jconrel.2008.08.019

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  21 in total

Review 1.  Remedial applications of silencing ribonucleic acids and modalities for its delivery to the kidneys--a review.

Authors:  Dongjie Wang; Yanfen Lv; Huifang Zhu; Guifeng Lv; Jiyi Huang
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-06-04

2.  Acoustic Cavitation-Mediated Delivery of Small Interfering Ribonucleic Acids with Phase-Shift Nano-Emulsions.

Authors:  Mark T Burgess; Tyrone M Porter
Journal:  Ultrasound Med Biol       Date:  2015-05-13       Impact factor: 2.998

3.  Effects of doxorubicin-encapsulating AG73 peptide-modified liposomes on tumor selectivity and cytotoxicity.

Authors:  Yoichi Negishi; Nobuhito Hamano; Daiki Omata; Azusa Fujisawa; Maya Manandhar; Motoyoshi Nomizu; Yukihiko Aramaki
Journal:  Results Pharma Sci       Date:  2011-10-13

Review 4.  Nucleic acid delivery with microbubbles and ultrasound.

Authors:  Joshua J Rychak; Alexander L Klibanov
Journal:  Adv Drug Deliv Rev       Date:  2014-01-31       Impact factor: 15.470

5.  Explorations of high-intensity therapeutic ultrasound and microbubble-mediated gene delivery in mouse liver.

Authors:  S Song; Z Shen; L Chen; A A Brayman; C H Miao
Journal:  Gene Ther       Date:  2011-03-31       Impact factor: 5.250

6.  Delivery of an angiogenic gene into ischemic muscle by novel bubble liposomes followed by ultrasound exposure.

Authors:  Yoichi Negishi; Keiko Matsuo; Yoko Endo-Takahashi; Kentaro Suzuki; Yuuki Matsuki; Norio Takagi; Ryo Suzuki; Kazuo Maruyama; Yukihiko Aramaki
Journal:  Pharm Res       Date:  2010-10-08       Impact factor: 4.200

Review 7.  Targeted renal therapies through microbubbles and ultrasound.

Authors:  Leo E Deelman; Anne-Emilie Declèves; Joshua J Rychak; Kumar Sharma
Journal:  Adv Drug Deliv Rev       Date:  2010-10-11       Impact factor: 15.470

Review 8.  Nanotherapy for Duchenne muscular dystrophy.

Authors:  Michael E Nance; Chady H Hakim; N Nora Yang; Dongsheng Duan
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-04-11

9.  Ultrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes.

Authors:  Rahul Nahire; Shirshendu Paul; Michael D Scott; Raushan K Singh; Wallace W Muhonen; John Shabb; Kara N Gange; D K Srivastava; Kausik Sarkar; Sanku Mallik
Journal:  Mol Pharm       Date:  2012-08-15       Impact factor: 4.939

10.  Enhancement of survivin gene downregulation and cell apoptosis by a novel combination: liposome microbubbles and ultrasound exposure.

Authors:  Zhiyi Chen; Kun Liang; Jianhua Liu; Mingxing Xie; Xinfang Wang; Qing Lü; Jing Zhang; Lingyun Fang
Journal:  Med Oncol       Date:  2009-01-07       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.